efavirenz
Efavirenz is a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor used to treat Acquired Immunodeficiency Syndrome.
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor · by Matrix Labs Ltd
Generic of Sustiva
Key facts
- Active ingredient
- Efavirenz
- Form
- Capsule, Tablet
- Strength
- Efavirenz 100MG · Efavirenz 200MG · Efavirenz 50MG
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- acquired immunodeficiency syndrome
- Manufacturer
- Matrix Labs Ltd
- What the pharmacy pays
- ~$42.28 for 30 — not your price
- FDA application
- NDA022461
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Capsule and Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Efavirenz treat?
- Efavirenz (Efavirenz) may be used to treat acquired immunodeficiency syndrome, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How much does Efavirenz cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $42.28 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Nevirapine — about $4.55 on the same basis.
- Is there a coupon or discount for Efavirenz?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Efavirenz. To pay less, Efavirenz is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Efavirenz?
- Efavirenz is marketed by Matrix Labs Ltd. You can see Matrix Labs Ltd's full profile, rating, and other products on pharmaranks.
- Is Efavirenz a brand-name or generic drug?
- Efavirenz is a generic medication; its active ingredient is Efavirenz. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Efavirenz available over the counter?
- No. Efavirenz is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Efavirenz come in?
- Efavirenz is currently marketed as capsule and tablet, per the FDA's National Drug Code Directory.
- What class of drug is Efavirenz?
- Efavirenz is classified as human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor, per the FDA's Established Pharmacologic Class.
- Is Efavirenz FDA-registered?
- Efavirenz is on record with the U.S. FDA under application number NDA022461. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Efavirenz head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
efavirenz
New